drug
SAT-3247
Phase 2updated 3mo agoby $MSLE Satellos Bioscience Inc.
Phase 2community read0 votes
indications
indications
Duchenne Muscular Dystrophy
all catalysts(0)
nothing on the calendar yet
Trials studying SAT-3247
- phase2Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients
- phase2An Open-label Long-term Follow-up Study of SAT-3247 for Participants With Duchenne Muscular Dystrophy Including Those Who Participated in SAT-3247-CL-101
- EP1First in Human SAD/MAD Safety and PK Study With Adult DMD Safety and PK Cohort
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 31m ago
Found something off?
comments(0)
5-min edit window · permanent after that